Board of directors

 
 

Peter Benson

Peter Benson – born 1955, Chairman since 2014 and Board member since 2011 – is a Swedish graduate in business administration from Lund University in Sweden and has an MA in Economics from the University of California. Peter Benson, who is currently Chairman and General Partner of Sunstone Capital Life Science Ventures has previously inter alia been Head of Life Science Investments for Vækstfonden (The Danish Growth Fund), President Pharmacia Hospital Care and member of Pharmacia AB’s group management. Benson has served on the board of a range of Life science companies, seven of which are listed on a public stock exchange.

Other current positions: Chairman of Ascelia AB and Good Partners AB. Board member of Arcoma Aktiebolag, Jollingham AB, Montela Aktiebolag, Opsona Therapeutics Ltd. and Sunstone Capital A/S.

Holdings in Alligator: None

Independent in relation to the Company, its senior management and major shareholders.

Carl Borrebaeck

Carl Borrebaeck – born 1948, Board member since 2001 - is a Professor at the Department of Immunotechnology and Programme Director of the CREATE Health Translational Cancer Research Centre at Lund University. Carl is a co-founder of Alligator and a board member of the Royal Swedish Academy of Engineering Sciences (IVA) and former Vice-Chancellor of Lund University. In 2009 Carl was awarded AkzoNobels Science Prize and 2012 he received IVA´s gold medal for his pioneering research on biomarkers. In 2017 he was designated as the Biotech builder of the Year for his entrepreneurship. He has founded five companies in life science and eHealth.

Other current positions: Chairman of Immunovia AB, SenzaGen AB and PainDrainer AB. Board member of Qlucore AB, Scandion AS and CB Ocean Capital AB. Partner of Immunova HB.

Holdings in Alligator: 1,200,833 shares

Non-independent in relation to the Company and its senior management, but independent in relation to major shareholders.

Ulrika Danielsson

Ulrika Danielsson – born 1972, Board member since 2016 – has an MBA from the Gothenburg School of Business, Economics and Law at the University of Gothenburg, and has been the CFO of Castellum AB (publ) since 2014. She has worked for the Castellum Group in various senior positions since 1998 and has been a member of the corporate management of Castellum since 2006.

Other current positions: Ulrika Danielsson is a Board member and deputy Board member respectively for a number of subsidiaries and second-tier subsidiaries within the Castellum Group, and Board member of Slättö Förvaltning AB and John Mattson Fastighetsföretagen AB.

Holdings in Alligator: None

Independent in relation to the Company, its senior management and major shareholders.

Anders Ekblom

Anders Ekblom – born 1954, Board member since 2017 – is a physician, board certified in anaesthesia and intensive care, dentist and Associate Professor in physiology at the Karolinska Institute. Anders Ekblom has extensive experience from the biopharmaceutical industry globally, including being EVP Global Medicines Development at AstraZeneca and CEO and president of AstraZeneca AB Sweden.

Other current positions: Chairman of TFS International AB and Elypta AB. Board member of AnaMar AB, Infant Bacterial Therapeutics AB, LEO Pharma A/S, Mereo BioPharma Group plc and NxtScience AB.

Holdings in Alligator: 19,658 shares

Independent in relation to the Company, its senior management and major shareholders.

Kenth Petersson

Kenth Petersson – born 1956, Board member since 2001 – has a BA from Lund University and has long experience of working in both the finance and biotechnology sectors, including as an analyst. He has been a business angel for more than 15 years and has founded a number of biotechnology companies.

Other current positions: Chairman of AlphaBeta AB, Biocrine AB, Biocrine Regenative Medicine AB and Spiber Technologies AB. Board member of Science Pacific AB and Genovis AB.

Holdings in Alligator: 408,000 shares

Independent in relation to the Company, its senior management and major shareholders.

Jonas Sjögren

Jonas Sjögren – born 1966, Board member since 2015 – is a Swedish graduate engineer in electrical engineering from Chalmers University of Technology, Registered medical doctor from the Sahlgrenska Academy (Faculty of Health Sciences at the University of Gothenburg), and has an MBA from INSEAD.

Other current positions: Chairman of Exceca Allocation AB, Alsteron AB and Markov Capital AB. Board member of Storytel AB (publ), Oblique Therapeutics AB and CMC SPV of 3 April 017 AB. Deputy Board member of Delibr AB.

Holdings in Alligator (private and via company): 4,936,388 shares

Independent in relation to the Company, its senior management and major shareholders.

Laura von Schantz

 

Laura von Schantz - born 1982, Board member since 2017 - is a Swedish graduate engineer in biotechnical engineering and has a doctorate in immuno-technology from Lund University. Is the board’s employee representative.

Other current positions: None

Holdings in Alligator: 25 000 employee option stocks in program 2018/2022.